Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.57 +0.04 (+2.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Return on Assets [ROA] (2021 - 2026)

Updated

Transcode Therapeutics' Return on Assets [ROA] came in at -29.09% for Q2 2026, up 191.15 percentage points from -220.23% a year earlier but down 2.58 percentage points from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Transcode Therapeutics' Return on Assets [ROA] was -40.59%, up 228.26 percentage points from FY2024.

  • Return on Assets [ROA] carries a four-year change of +11.47 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Assets [ROA] was -268.85% in FY2024 (+36.36 pp), -305.21% in FY2023 (-183.06 pp), -122.16% in FY2022 (-70.10 pp) and -52.06% in FY2021.
  • The five-year range for quarterly Return on Assets [ROA] is -385.72% (Q3 2025) to -3.90% (Q3 2021).
  • Year-over-year, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +76.00 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2025 (a gain of 235.36 percentage points), and the weakest in Q1 2023 (a drop of 275.06 percentage points).
  • Business Quant data shows RNAZ's Return on Assets [ROA] at -26.50% (Q1 2026), -44.00% (Q4 2025) and -385.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Transcode Therapeutics 1.59 Mn 1.59 Mn - -29.09%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.09%
Mar 31, 2026 -26.50%
Dec 31, 2025 -44.00%
Sep 30, 2025 -385.72%
Jun 30, 2025 -220.23%
Mar 31, 2025 -238.90%
Dec 31, 2024 -279.36%
Sep 30, 2024 -335.76%
Jun 30, 2024 -294.82%
Mar 31, 2024 -286.86%
Dec 31, 2023 -252.89%
Sep 30, 2023 -258.73%
Jun 30, 2023 -356.65%
Mar 31, 2023 -304.02%
Dec 31, 2022 -189.90%
Sep 30, 2022 -123.14%
Jun 30, 2022 -81.98%
Mar 31, 2022 -28.96%
Dec 31, 2021 -12.74%
Sep 30, 2021 -3.90%
API Access

Transcode Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RNAZ&period=max&api_key=YOUR_API_KEY